These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 37507689)

  • 1. Use of neuromuscular blockade for neck dissection and association with iatrogenic nerve injury.
    Smith JD; Mentz G; Leis AM; Yuan Y; Stucken CL; Chinn SB; Casper KA; Malloy KM; Shuman AG; McLean SA; Rosko AJ; Prince MEP; Tremper KK; Spector ME; Schechtman SA
    BMC Anesthesiol; 2023 Jul; 23(1):254. PubMed ID: 37507689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
    Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
    Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
    Hristovska AM; Duch P; Allingstrup M; Afshari A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the factors contributing to residual weakness after sugammadex administration in pediatric patients under 2 years of age.
    Cates AC; Freundlich RE; Clifton JC; Lorinc AN
    Paediatr Anaesth; 2024 Jan; 34(1):28-34. PubMed ID: 37792601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-Con Debate: Do We Need Quantitative Neuromuscular Monitoring in the Era of Sugammadex?
    Blobner M; Hollmann MW; Luedi MM; Johnson KB
    Anesth Analg; 2022 Jul; 135(1):39-48. PubMed ID: 35709443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Patients With Severe Renal Impairment: A Randomized, Double-Blinded Study.
    Oh MW; Mohapatra SG; Pak T; Hermawan A; Chen CA; Thota B; Chen J; Siu E; Park J; Moon TS
    Anesth Analg; 2024 May; 138(5):1043-1051. PubMed ID: 38190344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for administration of additional reversal following neuromuscular blockade with rocuronium in children: A retrospective case-control study.
    Vishneski SR; Saha AK; Fram MR; Templeton LB; Lee LK; Ririe DG; Goenaga-Diaz EJ; Smith LD; Templeton TW
    Paediatr Anaesth; 2022 Aug; 32(8):916-925. PubMed ID: 35438816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of intraoperative neuromuscular monitor reduces the reversal dose of sugammadex: a single-center retrospective study.
    Iwasaki H; Kurosawa A; Iida T; Sasakawa T; Kanda H
    J Anesth; 2020 Apr; 34(2):276-280. PubMed ID: 31993747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
    Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
    Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
    Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
    Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
    Mosing M; Auer U; West E; Jones RS; Hunter JM
    Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of neuromuscular blockade reversal in the evaluation of acute neurosurgical patients: A retrospective case-series.
    Christodoulides A; Palma S; Zaazoue MA; Huh A; Tobin MK; Dine SA; Huh M; Bradbury JL
    J Clin Neurosci; 2022 Oct; 104():82-87. PubMed ID: 35981464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
    Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
    Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
    Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I
    Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.